Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1. Kellihan HB, Stepien RL. Pulmonary hypertension in dogs: diagnosis and therapy. Vet Clin North Am Small Anim Pract 2010;40:623–641.
-
2. Kittleson MD. Diagnosis and treatment of arrhythmias (dysrhythmias). In: Kittleson MD, Kienle RD, eds. Small animal cardiovascular medicine. St Louis: Mosby, 1998;449–494.
-
3. Levy MN, Edflstein J. The mechanism of synchronization in isorhythmic AV dissociation. II. Clinical studies. Circulation 1970;42:689–699.
-
4. Ettinger S, Buergelt CD. Atrioventricular dissociation (incomplete) with accrochage in a dog with ruptured chordae tendinae. Am J Vet Res 1968;29:1499–1503.
-
5. Bright JM, Lombard CW. ECG of the month: atrioventricular junctional tachycardia producing atrioventricular dissociation. J Am Vet Med Assoc 1983;182:580–581.
-
6. Perego M, Ramera L, Santilli RA. Isorhythmic atrioventricular dissociation in Labrador Retrievers. J Vet Intern Med 2012;26:320–325.
-
7. Maudlin GE, Fox PR, Patnaik AK, et al. Doxorubicin-induced cardiotoxicosis: clinical features in 32 dogs. J Vet Intern Med 1992;6:82–88.
-
8. Sisson D, O'Grady MR, Calvert CA. Myocardial diseases of dogs. In: Fox PR, Sisson D, Moise NS, eds. Textbook of canine and feline cardiology. 2nd ed. Philadelphia: WB Saunders Co, 1999;581–619.
-
9. Zhang S, Liu X, Bawa-Khalfe T, et al. Identification of the molecular basis of doxorubicin-induced toxicity. Nat Med 2012;18:1639–1642.
-
10. Page RL, Keene BW. Doxorubicin cardiomyopathy. In: Kirk RW, Bonagura JD, eds. Kirk's current veterinary therapy XI. Philadelphia: WB Saunders Co, 1992;783–785.
-
11. Launchbury AP, Habboubi N. Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity, and toxicity. Cancer Treat Rev 1993;19:197–228.
-
12. Kim SE, Liptak JM, Gall TT, et al. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997–2004). J Am Vet Med Assoc 2007;231:1550–1557.
-
13. Ganzina F. 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data. Cancer Treat Rev 1983;10:1–22.
-
14. Sobic-Saranovic D, Pavlovic S, Susnjar S, et al. Assessment of early epirubicin cardiotoxicity in women with breast cancer. Anticancer Res 1997;17:3889–3891.
-
15. Gennari A, Salvadoria B, Donati S, et al. Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors. J Clin Oncol 1999;17:3596–3602.
-
16. Feenstra J, Grobbee DE, Remme WJ, et al. Drug-induced heart failure. J Am Coll Cardiol 1999;33:1152–1162.
Advertisement
ECG of the Month
Kelly E. Wiggen
 DVM
Kelly E. Wiggen
Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211.
Search for other papers by Kelly E. Wiggen in
Current site
Google Scholar
PubMed
Search for other papers by Kelly E. Wiggen in
Current site
Google Scholar
PubMed
Carley Saelinger
 VMD
Carley Saelinger
VCA Animal Specialty and Emergency Center, 1535 S Sepulveda Blvd, Los Angeles, CA 90025.
Search for other papers by Carley Saelinger in
Current site
Google Scholar
PubMed
Search for other papers by Carley Saelinger in
Current site
Google Scholar
PubMed
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1. Kellihan HB, Stepien RL. Pulmonary hypertension in dogs: diagnosis and therapy. Vet Clin North Am Small Anim Pract 2010;40:623–641.
-
2. Kittleson MD. Diagnosis and treatment of arrhythmias (dysrhythmias). In: Kittleson MD, Kienle RD, eds. Small animal cardiovascular medicine. St Louis: Mosby, 1998;449–494.
-
3. Levy MN, Edflstein J. The mechanism of synchronization in isorhythmic AV dissociation. II. Clinical studies. Circulation 1970;42:689–699.
-
4. Ettinger S, Buergelt CD. Atrioventricular dissociation (incomplete) with accrochage in a dog with ruptured chordae tendinae. Am J Vet Res 1968;29:1499–1503.
-
5. Bright JM, Lombard CW. ECG of the month: atrioventricular junctional tachycardia producing atrioventricular dissociation. J Am Vet Med Assoc 1983;182:580–581.
-
6. Perego M, Ramera L, Santilli RA. Isorhythmic atrioventricular dissociation in Labrador Retrievers. J Vet Intern Med 2012;26:320–325.
-
7. Maudlin GE, Fox PR, Patnaik AK, et al. Doxorubicin-induced cardiotoxicosis: clinical features in 32 dogs. J Vet Intern Med 1992;6:82–88.
-
8. Sisson D, O'Grady MR, Calvert CA. Myocardial diseases of dogs. In: Fox PR, Sisson D, Moise NS, eds. Textbook of canine and feline cardiology. 2nd ed. Philadelphia: WB Saunders Co, 1999;581–619.
-
9. Zhang S, Liu X, Bawa-Khalfe T, et al. Identification of the molecular basis of doxorubicin-induced toxicity. Nat Med 2012;18:1639–1642.
-
10. Page RL, Keene BW. Doxorubicin cardiomyopathy. In: Kirk RW, Bonagura JD, eds. Kirk's current veterinary therapy XI. Philadelphia: WB Saunders Co, 1992;783–785.
-
11. Launchbury AP, Habboubi N. Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity, and toxicity. Cancer Treat Rev 1993;19:197–228.
-
12. Kim SE, Liptak JM, Gall TT, et al. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997–2004). J Am Vet Med Assoc 2007;231:1550–1557.
-
13. Ganzina F. 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data. Cancer Treat Rev 1983;10:1–22.
-
14. Sobic-Saranovic D, Pavlovic S, Susnjar S, et al. Assessment of early epirubicin cardiotoxicity in women with breast cancer. Anticancer Res 1997;17:3889–3891.
-
15. Gennari A, Salvadoria B, Donati S, et al. Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors. J Clin Oncol 1999;17:3596–3602.
-
16. Feenstra J, Grobbee DE, Remme WJ, et al. Drug-induced heart failure. J Am Coll Cardiol 1999;33:1152–1162.
Advertisement
Powered by PubFactory